Trials / Completed
CompletedNCT01192347
French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia
A Phase 4, Observational Study to Explore How Different Treatment Regimens Affect Continuation With Treatment in the First 6 Months Following Initiation of XAGRID Into Adult Patients' Essential Thrombocythemia Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 177 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to explore how different treatment regimens affect continuation with treatment in the first 6 months following initiation of XAGRID into adult patients' essential thrombocythemia therapy.
Conditions
Timeline
- Start date
- 2010-09-13
- Primary completion
- 2012-12-21
- Completion
- 2012-12-21
- First posted
- 2010-09-01
- Last updated
- 2021-06-14
- Results posted
- 2013-09-25
Locations
46 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01192347. Inclusion in this directory is not an endorsement.